You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 87 No. 5, May 1963 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Rapid Fluorescent Screening Test for Skin Malignancy

MORRIS J. LIPNIK, MD

Arch Dermatol. 1963;87(5):575-583.


Abstract

Preliminary results are outlined of a fluorescent test for the screening of skin tumors. Tumors are tested by application of a 1% demethylchlortetracycline (Declomycin)-0.1% cyanocobalamin (vitamin B12) solution while under observation with the Wood's light (black light). A bright yellow-green fluorescence will be noted in tumors painted with the demethylchlortetracycline-cyanocobalamin solution. A challenge solution of 4.9% trichloracetic acid is then applied to the fluorescent area. If the test is negative, the green fluorescence disappears. If the test is positive, yellow-green fluorescence must remain within crusts and granules of the tumor through a ten-second test period. Of a large variety of tumors tested, basal cell epitheliomas, squamous cell carcinomas, Bowen's disease (squamous cell carcinoma in situ), and certain senile keratoses were found to show a positive test. In screening these malignant and premalignant tumors, 68 of 75 tumors tested gave a positive test. Of 191 benign tumors tested, 186 showed a negative test.



Author Affiliations

DETROIT

From the Department of Medicine, Sinai Hospital of Detroit, Section of Dermatology.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Fluorescent Test for Skin Malignancy
BURROWS
Arch Dermatol 1964;90:411-411.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1963 American Medical Association. All Rights Reserved.